Identification of gene polymorphism in lipocalin-type prostaglandin D synthase and its association with carotid atherosclerosis in Japanese hypertensive patients

Biochemical and Biophysical Research Communications

Volumn 322, Issue 2, 2004, Pages 428-433

  Miwa, Yoshikazu ^a,b   Takiuchi, Shin ^a   Kamide, Kei ^a   Yoshii, Masayoshi ^a   Horio, Takeshi ^a   Tanaka, Chihiro ^a   Banno, Mariko ^a   Miyata, Toshiyuki ^a   Sasaguri, Toshiyuki ^b   Kawano, Yuhei ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Carotid artery; Clinical genetics; Genetic polymorphism; HDL cholesterol; Hypertension; Intima media thickness; Lipocalin type prostaglandin D synthase

Indexed keywords

AMINO ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEUCINE; LIPOCALIN; PROSTAGLANDIN D SYNTHASE; VALINE; ISOMERASE; PROSTAGLANDIN R2 D ISOMERASE; PROSTAGLANDIN R2 D-ISOMERASE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTERY INTIMA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; COMMON CAROTID ARTERY; CONTROLLED STUDY; DISEASE SEVERITY; EXON; FEMALE; GENE IDENTIFICATION; GENOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; JAPAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; THICKNESS; ARTERIOSCLEROSIS; CAROTID ARTERY; CAROTID ARTERY DISEASE; DNA SEQUENCE; GENETIC POLYMORPHISM; GENETICS; HISTOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHENOTYPE; REGRESSION ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; FEMALE; HUMANS; HYPERTENSION; INTRAMOLECULAR OXIDOREDUCTASES; JAPAN; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; SEQUENCE ANALYSIS, DNA;

EID: 6044229643     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.07.143     Document Type: Article

References (34)

1. Y. Urade, N. Fujimoto, and O. Hayaishi Purification and characterization of rat brain prostaglandin D synthetase J. Biol. Chem. 260 1985 12410 12415
2. Y. Urade, and O. Hayaishi Prostaglandin D synthase: structure and function Vitam. Horm. 58 2000 89 120
3. Y. Urade, and O. Hayaishi Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase Biochim. Biophys. Acta 1482 2000 259 271
4. Y. Urade, and O. Hayaishi Prostaglandin D2 and sleep regulation Biochim. Biophys. Acta 1436 1999 606 615
5. A. Mizoguchi, N. Eguchi, K. Kimura, Y. Kiyohara, W.M. Qu, Z.L. Huang, T. Mochizuki, M. Lazarus, T. Kobayashi, T. Kaneko, S. Narumiya, Y. Urade, and O. Hayaishi Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep Proc. Natl. Acad. Sci. USA 98 2001 11674 11679
6. N. Eguchi, T. Minami, N. Shirafuji, Y. Kanaoka, T. Tanaka, A. Nagata, N. Yoshida, Y. Urade, S. Ito, and O. Hayaishi Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice Proc. Natl. Acad. Sci. USA 96 1999 726 730
7. 2 synthase expression in vascular endothelial cells Circ. Res. 86 2000 967 973
8. Y. Eguchi, N. Eguchi, H. Oda, K. Seiki, Y. Kijima, Y. Matsu-ura, Y. Urade, and O. Hayaishi Expression of lipocalin-type prostaglandin D synthase (beta-trace) in human heart and its accumulation in the coronary circulation of angina patients Proc. Natl. Acad. Sci. USA 94 1997 14689 14694
9. T. Inoue, K. Takayanagi, S. Morooka, Y. Uehara, H. Oda, K. Seiki, H. Nakajima, and Y. Urade Serum prostaglandin D synthase level after coronary angioplasty may predict occurrence of restenosis Thromb. Haemost. 85 2001 165 170
10. N. Hirawa, Y. Uehara, M. Yamakado, Y. Toya, T. Gomi, T. Ikeda, Y. Eguchi, M. Takagi, H. Oda, K. Seiki, Y. Urade, and S. Umemura Lipocalin-type prostaglandin D synthase in essential hypertension Hypertension 39 2002 449 454
11. H. Nagoshi, Y. Uehara, F. Kanai, S. Maeda, T. Ogura, A. Goto, T. Toyo-oka, H. Esumi, T. Shimizu, and M. Omata Prostaglandin D2 inhibits inducible nitric oxide synthase expression in rat vascular smooth muscle cells Circ. Res. 82 1998 204 209
12. H. Negoro, W. Soo Shin, R. Hakamada-Taguchi, N. Eguchi, Y. Urade, A. Goto, T. Toyo-Oka, T. Fujita, M. Omata, and Y. Uehara Endogenous prostaglandin D2 synthesis reduces an increase in plasminogen activator inhibitor-1 following interleukin stimulation in bovine endothelial cells J. Hypertens. 20 2002 1347 1354
13. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
14. C. Jiang, A.T. Ting, and B. Seed PPAR-γ agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
15. N. Marx, G. Sukhova, C. Murphy, P. Libby, and J. Plutzky Macrophages in human atheroma contain PPARγ: differentiation-dependent peroxisomal proliferator-activated receptor γ (PPARγ) expression and reduction of MMP-9 activity through PPARγ activation in mononuclear phagocytes in vitro Am. J. Pathol. 153 1998 17 23
16. T. Sasaguri, J. Masuda, K. Shimokado, T. Yokota, C. Kosaka, M. Fujishima, and J. Ogata Prostaglandins A and J arrest the cell cycle of cultured vascular smooth muscle cells without suppression of c-myc expression Exp. Cell. Res. 200 1992 351 357
17. 1 arrest and differentiation marker expression in vascular smooth muscle cells Mol. Pharmacol. 58 2000 837 844
18. 2-induced vascular smooth muscle cell differentiation Biochem. Biophys. Res. Commun. 319 2004 163 168
19. S.E. Antonarakis Recommendations for a nomenclature system for human gene mutations. nomenclature working group Hum. Mutat. 11 1998 1 3
20. C. Tanaka, K. Kamide, S. Takiuchi, Y. Miwa, M. Yoshii, Y. Kawano, and T. Miyata An alternative fast and convenient genotyping method for the screening of angiotensin converting enzyme gene polymorphisms Hypertens. Res. 26 2003 301 306
21. D.M. White, T. Takeda, L.J. DeGroot, K. Stefansson, and B.G. Arnason Beta-trace gene expression is regulated by a core promoter and a distal thyroid hormone response element J. Biol. Chem. 272 1997 14387 14393
22. K. Fujimori, Y. Fujitani, K. Kadoyama, H. Kumanogoh, K. Ishikawa, and Y. Urade Regulation of lipocalin-type prostaglandin D synthase gene expression by Hes-1 through E-box and interleukin-1 beta via two NF-kappa B elements in rat leptomeningeal cells J. Biol. Chem. 278 2003 6018 6026
23. M. Otsuki, H. Gao, K. Dahlman-Wright, C. Ohlsson, N. Eguchi, Y. Urade, and J.A. Gustafsson Specific regulation of lipocalin-type prostaglandin D synthase in mouse heart by estrogen receptor beta Mol. Endocrinol. 17 2003 1844 1855
24. S.K. Karathanasis, R.A. Norum, V.I. Zannis, and J.L. Breslow An inherited polymorphism in the human apolipoprotein A-I gene locus related to the development of atherosclerosis Nature 301 1983 718 720
25. C. Gerdes, L.U. Gerdes, P.S. Hansen, and O. Faergeman Polymorphisms in the lipoprotein lipase gene and their associations with plasma lipid concentrations in 40-year-old Danish men Circulation 92 1995 1765 1769
26. S.M. Clee, A.H. Zwinderman, J.C. Engert, K.Y. Zwarts, H.O. Molhuizen, K. Roomp, J.W. Jukema, M. van Wijland, M. van Dam, T.J. Hudson, A. Brooks-Wilson, J. Genest Jr., J.J. Kastelein, and M.R. Hayden Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease Circulation 103 2001 1198 1205
27. S. Kakko, M. Tamminen, M. Paivansalo, H. Kauma, A.O. Rantala, M. Lilja, A. Reunanen, Y.A. Kesaniemi, and M.J. Savolainen Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness Eur. J. Clin. Invest. 31 2001 593 602
28. S.H. Hong, J. Song, W.K. Min, and J.Q. Kim Genetic variations of the paraoxonase gene in patients with coronary artery disease Clin. Biochem. 34 2001 475 481
29. W.M. Lee, C. Lin, and T. Curran Activation of the transforming potential of the human fos proto-oncogene requires message stabilization and results in increased amounts of partially modified fos protein Mol. Cell. Biol. 8 1988 5521 5527
30. P.J. Good The role of elav-like genes, a conserved family encoding RNA-binding proteins, in growth and development Semin. Cell. Dev. Biol. 8 1997 577 584
31. W. Zhang, B.J. Wagner, K. Ehrenman, A.W. Schaefer, C.T. DeMaria, D. Crater, K. DeHaven, L. Long, and G. Brewer Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1 Mol. Cell. Biol. 13 1993 7652 7665
32. T. Henics, E. Nagy, H.J. Oh, P. Csermely, A. von Gabain, and J.R. Subjeck Mammalian Hsp70 and Hsp110 proteins bind to RNA motifs involved in mRNA stability J. Biol. Chem. 274 1999 17318 17324
33. S. Peters, B. Gotting, M. Trummel, H. Rust, and A. Brattstrom Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial J. Invasive Cardiol. 13 2001 93 97
34. ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials, Circulation 97 (1998) 2202-2212